Inhibition of CDK4/6 has been shown to favour the elimination of tumour cells by the adaptive immune system through various mechanisms including enhanced antigen presentation by cancer cells, increased infiltration and activation of T cells; and inhibition of regulatory T cells proliferation [29, 30, 128, 129, 130]. This evidence concerns the gene CDK4 and cancer.